APA-viite

Schlegel, P., Lang, P., Zugmaier, G., Ebinger, M., Kreyenberg, H., Witte, K., . . . Handgretinger, R. (2014). Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab. Ferrata Storti Foundation.

Chicago-tyylinen lähdeviittaus

Schlegel, Patrick, et al. Pediatric Posttransplant Relapsed/refractory B-precursor Acute Lymphoblastic Leukemia Shows Durable Remission By Therapy With the T-cell Engaging Bispecific Antibody Blinatumomab. Ferrata Storti Foundation, 2014.

MLA-viite

Schlegel, Patrick, et al. Pediatric Posttransplant Relapsed/refractory B-precursor Acute Lymphoblastic Leukemia Shows Durable Remission By Therapy With the T-cell Engaging Bispecific Antibody Blinatumomab. Ferrata Storti Foundation, 2014.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.